Stock MOTS MOTUS GI HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Motus GI Holdings, Inc.

Equities

MOTS

US62014P5044

Delayed OTC Markets
Other stock markets
 10:46:44 26/06/2024 pm IST 		5-day change 1st Jan Change
0.0488 USD +17.90% Intraday chart for Motus GI Holdings, Inc. +35.56% -96.17%
14/05 Motus GI Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
18/04 Motus GI Holdings, Inc.(OTCPK:MOTS) dropped from S&P TMI Index CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Motus GI Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Earnings Flash (MOTS) MOTUS GI HOLDINGS Reports Q4 Revenue $64,000
MT
Motus GI Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Motus GI Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Motus GI Holdings, Inc. Publishes Positive Results from A European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with A History of Poor Bowel Preparation
CI
Exchange-Traded Funds, US Equities Rise Pre-Bell Tuesday as Investors Continue to Hope for Federal Reserve Rate Cuts Soon
MT
Earnings Flash (MOTS) MOTUS GI HOLDINGS Reports Q3 Revenue $86,000
MT
Motus GI Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Motus GI Holdings, Inc. Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu®? EVS Gastro
CI
Motus GI Holdings, Inc. Receives Fda Clearance to Commercialize Pure-Vu Evs Gastro and Gen 4 Colon
CI
Motus Gi Submits Special 510(K) to Fda for Pure-Vu Evs Gen 4 Gastro and Colon
CI
Earnings Flash (MOTS) MOTUS GI HOLDINGS Posts Q2 Revenue $113,000
MT
Motus GI Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Motus GI Holdings, Inc. Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of Its Pure-Vu® EVS System
CI
Motus GI Holdings, Inc. Announces Banner Desert Medical Center Purchases and Initiates Implementation of Pure-Vu System
CI
Motus GI Announces Pure-Vu Gen 4 Gastro and Colon System Featured at 9th IECED Live Endoscopy Course 2023 At the Pentax Learning Center
CI
Motus GI Holdings, Inc. Completes First Clinical Evaluation of New Pure-Vu(R) Gastro in Upper Gastrointestinal Procedures to Support Fda Submission
CI
Earnings Flash (MOTS) MOTUS GI HOLDINGS Reports Q1 Revenue $56,000
MT
Motus GI Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Motus GI Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MOTS Stock
  4. News Motus GI Holdings, Inc.
  5. Highlights